The number of human NK cells expressing the PVR receptor CD112R or TIGIT (CD56+) decreases with decreased IFN-γ production in CD112-positive breast cancer, indicating that CD112R engagement with the ligand CD112 suppresses NK cell cytotoxicity [49]. The gene discussed is TIGIT; the disease is breast carcinoma.